SCHEMBL720913

SCHEMBL720913

CS(=O)(=O)c1ccc(-c2ccc(C(=O)N[C@H]3CC[C@H](O)CC3)c(F)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
NAAA Q02083 2/20 0.44
MAPK1 P28482 2/20 0.44
ALOX5AP P20292 1/20 0.44
FEN1 P39748 1/20 0.44
KIF11 P52732 1/20 0.43
RIPK2 O43353 1/20 0.43
BMPR1B O00238 1/20 0.43
BMPR1A P36894 1/20 0.43
TGFBR1 P36897 1/20 0.43
ACVRL1 P37023 1/20 0.43
ACVR1 Q04771 1/20 0.43
HPGD P15428 2/20 0.42
ATR Q13535 1/20 0.41
MAPK14 Q16539 1/20 0.41
LRRK2 Q5S007 1/20 0.41
CDK2AP1 O14519 1/20 0.41
CHEK1 O14757 1/20 0.41
USP30 Q70CQ3 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL720914 1.00 KMT2A (0.47) KMT2ANAAAMAPK1ALOX5APFEN1
SCHEMBL10052770 0.85 TAS1R3 (0.49) KMT2ANAAAALOX5APFEN1BMPR1B
SCHEMBL718622 0.81 HRH3 (0.41) KMT2ANAAAMAPK1RIPK2HPGD
SCHEMBL720786 0.78 GPR119 (0.41) NAAAMAPK1RIPK2ATRUSP30
SCHEMBL722526 0.74 KIF11 (0.56) KIF11
Hydrochloric Acid SCHEMBL4733281 0.73 PDE4B (0.50) KMT2AALDH1A1
SCHEMBL14831146 0.72 IDH1 (0.49) ALOX5APFEN1BMPR1BBMPR1ATGFBR1
SCHEMBL14831145 0.72 IDH1 (0.49) ALOX5APFEN1BMPR1BBMPR1ATGFBR1
SCHEMBL10282411 0.71 TAS1R3 (0.62) KMT2AHPGDMAPK14ALDH1A1SMN1; SMN2
SCHEMBL718908 0.71 PTGS2 (0.46) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053180-A1 CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-03-01 US disclosed
US-20120053180-A1 CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-03-01 US disclosed
US-20120053180-A1 CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS CHEMIZON, A DIVISION OF OPTOMAGIC CO., LTD. (KR) 2012-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120053180-A1 CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS GPR119, GLP1R, GIPR KMT2A 3229/4885NAAA 2254/4885MAPK1 1482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.